Thrombocytopenia Treatment Market Size, Share, Outlook, and Opportunity Analysis 2018–2026

Thrombocytopenia Treatment Market

                    Thrombocytopenia Treatment Market




Thrombocytopenia is an auto immune haematological bleeding condition characterised by a lack of platelets in the blood vessels. To overcome thrombocytopenia, the platelet count must be regularly maintained at a safe range. Thrombocytopenia can develop in people with a platelet count of fewer than 100,000 platelets/L owing to a decrease in megakaryocytes in the bone marrow, drugs that destroy platelets, and immunological diseases.


Blood in the urine, headaches, heavy menstrual periods, skin patches, and bruises are all symptoms of thrombocytopenia. Cancer treatments, such as chemotherapy and drug-induced medicines, as well as radiation therapy, can cause thrombocytopenia.


The global incidence of thrombocytopenia is driving the thrombocytopenia treatment market. Chronic Hepatitis C patients are at a substantially increased risk of developing thrombocytopenia. According to the World Health Organization (WHO), in 2014, the prevalence of Hepatitis C in the Americas and Europe was lower than in Africa and Pakistan, where the incidence of chronic liver disease was 4-6 percent greater than in the Americas and Europe. Because 60-80 percent of the population suffers liver disease, it has become a socioeconomic and worldwide health issue.


Additionally, rising government support for fast-track approval in order to discover newer treatments for this disorder, as well as increased investment in the development of new drugs by biotechnology and pharmaceutical companies, are expected to drive the thrombocytopenia treatment market forward during the forecast period. However, due to patent expiry and the rising availability of generic versions of Promacta and MabThera, the thrombocytopenia treatment market is expected to slow significantly from 2023.


Market Segmentation:

By Drug Class:
  • Glucocorticoids
  • Lysosomal Enzyme
  • Platelet Stimulating Agent


By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The major key players in thrombocytopenia treatment market include 3SBio Inc., Amarillo Biosciences, Inc., Amgen Inc., Baxalta Incorporated, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cellerant Therapeutics, Inc., Eisai Co., Ltd., Hansa Medical AB, Intas Pharmaceuticals Ltd., Merck & Co., Inc., Momenta Pharmaceuticals, Inc., Myelo Therapeutics GmbH, Neumedicines Inc., Novartis AG, Pfizer Inc., Prophylix Pharma AS, Rigel Pharmaceuticals, Inc., Shionogi & Co., Ltd., STATegics, Inc., and ViroMed Co., Ltd.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Earphone and Headphones Market - Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027 | Harman International Industries, Inc. (AKG), Beats (Apple Inc.), Plantronics Pty. Limited

Image
The Active Noise Cancellation technology, which is used in Earphones and Headphones, aids in improving the listening experience. An electro-acoustic transducer converts electrical signals into sound in these gadgets; they are small loudspeakers. It connects to the source signal both wirelessly and with a wired connection. Headphones and earphones are available in a variety of styles, all of them easily worn and comfortable. The newest advancements in the field of personal computers, including as desktops and laptops, have resulted in a considerable expansion in the worldwide Earphones and Headphones market , resulting in the creation of new processors and other system components. The global expansion of the automobile sector is being driven by the rising usage of electronic gadgets such as improved GPS (Global positioning system), car entertainment, parking systems, and the driving assistant. Due to consumers' constantly evolving desire for better listening experiences, the Earph...
Read more